{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:34:04Z","timestamp":1790505244835,"version":"4.1.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology"},{"name":"Grants-in-Aid from Japan Promotion of Science","award":["17H07419"],"award-info":[{"award-number":["17H07419"]}]},{"name":"Grants-in-Aid from Japan Promotion of Science","award":["18H02725"],"award-info":[{"award-number":["18H02725"]}]},{"name":"Grants-in-Aid from Japan Promotion of Science","award":["MEXT15K15272"],"award-info":[{"award-number":["MEXT15K15272"]}]},{"name":"Grants-in-Aid from Japan Promotion of Science","award":["MEXT17H04154"],"award-info":[{"award-number":["MEXT17H04154"]}]},{"name":"Grants-in-Aid from Japan Promotion of Science","award":["16H06277"],"award-info":[{"award-number":["16H06277"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP20dm0107106"],"award-info":[{"award-number":["JP20dm0107106"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda Science Foundation Research Encouragement Grant"},{"DOI":"10.13039\/501100008593","name":"Japan Foundation For Aging And Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yokoyama Foundation for Clinical Pharmacology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite the routine use of sandwich enzyme-linked immunosorbent assays (ELISAs) for quantifying tau levels in CSF and plasma, tau accumulations in the brains of patients with Alzheimer disease (AD) have rarely been evaluated by this method. Thus, by introducing several tau ELISAs that target different epitopes, we evaluated accumulated tau levels in postmortem brains depending on disease stage, brain areas, and other AD-related changes. Notably, tau levels in insoluble fraction determined by each ELISAs differ depending on the epitopes of antibodies: non-AD control samples yield relatively high signals when an antibody against the N-terminal region of tau is used. On the other hand, ELISAs combining antibodies against the later-middle to C-terminal regions of tau produced substantially increased signals from AD samples, compared to those from non-AD controls. Such ELISAs better distinguish AD and non-AD controls, and the results are more closely associated with Braak neurofibrillary tangles stage, A\u03b2 accumulation, and glial markers. Moreover, these ELISAs can reflect the pattern of tau spread across brain regions. In conclusion, Tau ELISAs that combine antibodies against the later-middle to C-terminal regions of tau can better reflect neuropathological tau accumulation, which would enable to evaluate tau accumulation in the brain at a biochemical level.<\/jats:p>","DOI":"10.1093\/jnen\/nlab047","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T12:40:28Z","timestamp":1626784828000},"page":"652-662","source":"Crossref","is-referenced-by-count":15,"title":["ELISA Evaluation of Tau Accumulation in the Brains of Patients with Alzheimer Disease"],"prefix":"10.1093","volume":"80","author":[{"given":"Mitsuru","family":"Shinohara","sequence":"first","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"},{"name":"Department of Aging Neurobiology, Graduate School of Medicine, Osaka University , Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hirokawa","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Graduate School of Medicine, Osaka University , Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Shimodaira","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghupurjan","family":"Gheni","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Fukumori","sequence":"additional","affiliation":[{"name":"Department of Aging Neurobiology, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology From the , Obu, Aichi, Japan"},{"name":"Department of Aging Neurobiology, Graduate School of Medicine, Osaka University , Suita, Osaka, Japan"},{"name":"Department of Pharmacotherapeutics II, Osaka University of Pharmaceutical Sciences , Takatsuki, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology , Itabashi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology , Itabashi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology , Itabashi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Neuropathology (The Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology , Itabashi, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University , Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2024032523404986000_nlab047-B1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"2024032523404986000_nlab047-B2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies","volume":"8","author":"Brunden","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"2024032523404986000_nlab047-B3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"2024032523404986000_nlab047-B4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/17460441.2018.1445084","article-title":"Recent developments with tau-based drug discovery","volume":"13","author":"Iqbal","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"2024032523404986000_nlab047-B5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat Neurosci"},{"key":"2024032523404986000_nlab047-B6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"2024032523404986000_nlab047-B7","first-page":"1129","article-title":"\u00dcber einen eigenartigen schweren Erkrankungsproze\u00df der Hirnrinde","volume":"23","author":"Alzheimer","year":"1906","journal-title":"Neurolog Centralbl"},{"key":"2024032523404986000_nlab047-B8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/neup.12144","article-title":"Simplification of the modified Gallyas method","volume":"35","author":"Kuninaka","year":"2015","journal-title":"Neuropathology"},{"key":"2024032523404986000_nlab047-B10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00005072-198705000-00003","article-title":"Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles","volume":"46","author":"Terry","year":"1987","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523404986000_nlab047-B11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/002215540205000403","article-title":"Comparative analysis of an improved Thioflavin-S stain, gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections","volume":"50","author":"Sun","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"2024032523404986000_nlab047-B12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol"},{"key":"2024032523404986000_nlab047-B13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.3083509","article-title":"A neuronal antigen in the brains of Alzheimer patients","volume":"232","author":"Wolozin","year":"1986","journal-title":"Science"},{"key":"2024032523404986000_nlab047-B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer's disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J"},{"key":"2024032523404986000_nlab047-B16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B17","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/oxfordjournals.jbchem.a135625","article-title":"One of the antigenic determinants of paired helical filaments is related to tau protein","volume":"99","author":"Nukina","year":"1986","journal-title":"J Biochem"},{"key":"2024032523404986000_nlab047-B18","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032523404986000_nlab047-B19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0896-6273(93)90063-W","article-title":"Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments","volume":"10","author":"Morishima-Kawashima","year":"1993","journal-title":"Neuron"},{"key":"2024032523404986000_nlab047-B20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-015-1503-3","article-title":"Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau","volume":"131","author":"Taniguchi-Watanabe","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"JAD"},{"key":"2024032523404986000_nlab047-B22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"2024032523404986000_nlab047-B23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry"},{"key":"2024032523404986000_nlab047-B24","first-page":"452","article-title":"High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy","volume":"145","author":"Suzuki","year":"1994","journal-title":"Am J Pathol"},{"key":"2024032523404986000_nlab047-B25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann Neurol"},{"key":"2024032523404986000_nlab047-B26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(95)00162-J","article-title":"Amyloid \u03b2 protein 1\u201342\/43 (A\u03b2 1\u201342\/43) in cerebellar diffuse plaques: Enzyme-linked immunosorbent assay and immunocytochemical study","volume":"679","author":"Tamaoka","year":"1995","journal-title":"Brain Res"},{"key":"2024032523404986000_nlab047-B27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(96)00314-0","article-title":"Amyloid \u03b2 protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease","volume":"148","author":"Tamaoka","year":"1997","journal-title":"J Neurol Sci"},{"key":"2024032523404986000_nlab047-B28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-61779-551-0_34","article-title":"A\u03b2 measurement by enzyme-linked immunosorbent assay","volume":"849","author":"Schmidt","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2024032523404986000_nlab047-B29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer's disease: Moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol Ther"},{"key":"2024032523404986000_nlab047-B30","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J Neurochem"},{"key":"2024032523404986000_nlab047-B31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer's disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"2024032523404986000_nlab047-B32","doi-asserted-by":"crossref","first-page":"e76523","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF tau and ptau biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PLOS One"},{"key":"2024032523404986000_nlab047-B33","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523404986000_nlab047-B34","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1440-1789.2007.00806.x","article-title":"Neuropathology of mild cognitive impairment","volume":"27","author":"Saito","year":"2007","journal-title":"Neuropathology"},{"key":"2024032523404986000_nlab047-B35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1440-1789.2004.00571.x","article-title":"Neuropathological diagnostic criteria for Alzheimer's disease","volume":"24","author":"Murayama","year":"2004","journal-title":"Neuropathology"},{"key":"2024032523404986000_nlab047-B36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","article-title":"Incidence and extent of TDP-43 accumulation in aging human brain","volume":"3","author":"Uchino","year":"2015","journal-title":"Acta Neuropathol Comm"},{"key":"2024032523404986000_nlab047-B37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): A common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-013-1086-9","article-title":"Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: Potential mechanisms underlying regional vulnerability to amyloid-beta accumulation","volume":"125","author":"Shinohara","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B39","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/awu046","article-title":"Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease","volume":"137","author":"Shinohara","year":"2014","journal-title":"Brain"},{"key":"2024032523404986000_nlab047-B40","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/brain\/awx284","article-title":"Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-\u03b242 in Alzheimer's disease","volume":"140","author":"Shinohara","year":"2017","journal-title":"Brain"},{"key":"2024032523404986000_nlab047-B41","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1096\/fj.201901028RR","article-title":"Increased levels of A\u03b242 decrease the lifespan of ob\/ob mice with dysregulation of microglia and astrocytes","volume":"34","author":"Shinohara","year":"2020","journal-title":"FASEB J"},{"key":"2024032523404986000_nlab047-B42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2007.04.187","article-title":"Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein","volume":"358","author":"Porzig","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032523404986000_nlab047-B43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res"},{"key":"2024032523404986000_nlab047-B44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00389492","article-title":"Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition","volume":"88","author":"Yamaguchi","year":"1994","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0006-8993(86)91460-5","article-title":"Paired helical filaments associated with Alzheimer disease are readily soluble structures","volume":"372","author":"Rubenstein","year":"1986","journal-title":"Brain Res"},{"key":"2024032523404986000_nlab047-B46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0197-4580(92)90039-Z","article-title":"Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filaments","volume":"13","author":"Caputo","year":"1992","journal-title":"Neurobiol Aging"},{"key":"2024032523404986000_nlab047-B47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","article-title":"Correlations of synaptic and pathological markers with cognition of the elderly","volume":"16","author":"Dickson","year":"1995","journal-title":"Neurobiol Aging"},{"key":"2024032523404986000_nlab047-B48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2005.11.001","article-title":"Tau protein abnormalities associated with the progression of alzheimer disease type dementia","volume":"28","author":"Haroutunian","year":"2007","journal-title":"Neurobiol Aging"},{"key":"2024032523404986000_nlab047-B49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcla.1860040308","article-title":"A sandwich enzyme immunoassay for detecting and measuring Alzheimer's disease\u2013associated proteins in human brain tissue","volume":"4","author":"Ghanbari","year":"1990","journal-title":"J Clin Lab Anal"},{"key":"2024032523404986000_nlab047-B50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(95)11617-6","article-title":"New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins","volume":"192","author":"Condamines","year":"1995","journal-title":"Neurosci Lett"},{"key":"2024032523404986000_nlab047-B51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000008108","article-title":"ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain","volume":"42","author":"Herrmann","year":"1999","journal-title":"Eur Neurol"},{"key":"2024032523404986000_nlab047-B52","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.6120571","article-title":"Alzheimer's disease: Insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea","volume":"215","author":"Selkoe","year":"1982","journal-title":"Science"},{"key":"2024032523404986000_nlab047-B53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(98)00441-7","article-title":"Duration of neurofibrillary changes in the hippocampal pyramidal neurons","volume":"799","author":"Bobinski","year":"1998","journal-title":"Brain Res"},{"key":"2024032523404986000_nlab047-B54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00309621","article-title":"Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease","volume":"89","author":"Cras","year":"1995","journal-title":"Acta Neuropathol"},{"key":"2024032523404986000_nlab047-B55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2004.09.019","article-title":"Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease","volume":"26","author":"Guillozet-Bongaarts","year":"2005","journal-title":"Neurobiol Aging"},{"key":"2024032523404986000_nlab047-B56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-150962","article-title":"Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer's disease, progressive supranuclear palsy, and dementia with lewy bodies","volume":"51","author":"Barth\u00e9lemy","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2024032523404986000_nlab047-B57","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"2024032523404986000_nlab047-B58","doi-asserted-by":"crossref","first-page":"eaaz2387","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci Adv"},{"key":"2024032523404986000_nlab047-B59","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","article-title":"Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression","volume":"142","author":"Yamazaki","year":"2019","journal-title":"Brain"},{"key":"2024032523404986000_nlab047-B60","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1038\/srep15709","article-title":"Rapid alteration of protein phosphorylation during postmortem: Implication in the study of protein phosphorylation","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"2024032523404986000_nlab047-B61","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.npp.1300112","article-title":"Post-mortem interval effects on the phosphorylation of signaling proteins","volume":"28","author":"Li","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"2024032523404986000_nlab047-B62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0197-4580(98)00094-3","article-title":"Postmortem changes in the phosphorylation state of tau-protein in the rat brain","volume":"19","author":"G\u00e4rtner","year":"1998","journal-title":"Neurobiol Aging"},{"key":"2024032523404986000_nlab047-B63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","article-title":"Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: Pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome","volume":"12","author":"Tatebe","year":"2017","journal-title":"Mol Neurodegener"},{"key":"2024032523404986000_nlab047-B64","doi-asserted-by":"crossref","first-page":"e11170","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol Med"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/7\/652\/39679604\/nlab047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/7\/652\/39679604\/nlab047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:10:58Z","timestamp":1711411858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/80\/7\/652\/6324484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2021,8,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlab047","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,7,1]]}}}